trending Market Intelligence /marketintelligence/en/news-insights/trending/GcF27Z7rdwsfpLZiy5NPCQ2 content esgSubNav
In This List

Haemonetics to move HQ to Boston

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Haemonetics to move HQ to Boston

Haemonetics Corp. will relocate its global headquarters to downtown Boston from Braintree, Mass., under a multiyear lease signed through 2032.

The medical technology company expects to move more than 200 headquarters-based posts to the new hub. Its 40-acre campus in Braintree is up for sale.

The move is expected to take place in 2019.